First-in-man study of tafluposide, a novel inhibitor of topoisomerase I and II

被引：0
|
作者：
Delord, Jean-Pierre [1 ]
Bennouna, Jaafar [2 ]
Dieras, Veronique [3 ]
Campone, Mario [2 ]
Lefresne, Florence [4 ]
Aslanis, Vassili [5 ]
Douillard, Jean-Yves [2 ]
机构：
[1] Inst Claudius Regaud, Toulouse, France
[2] Ctr Rene Gauducheau, F-44035 Nantes, France
[3] Inst Curie, Paris, France
[4] Inst Rech Pierre Fabre, Boulogne, France
[5] Inst Rech Pierre Fabre, Castres, France
来源：
MOLECULAR CANCER THERAPEUTICS | 2007年 / 6卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3380S / 3380S
页数：1
相关论文
共 50 条
  • [1] Calcium Electroporation for Keloids: A First-in-Man Phase I Study
    Falk, Hanne
    Vissing, Mille
    Wooler, Gitte
    Gehl, Julie
    DERMATOLOGY, 2021, 237 (06) : 961 - 969
  • [2] First-in-Man Study of a Novel Peripheral Plaque Atherectomy Device
    Wang, Hui
    Pan, Dikang
    Cui, Shijun
    Tong, Zhu
    Gao, Xixiang
    Gu, Yongquan
    Guo, Jianming
    Guo, Lianrui
    JOURNAL OF CLINICAL HYPERTENSION, 2025, 27 (01):
  • [3] Phase I and pharmacokinetic study of DACA (XR5000): a novel inhibitor of topoisomerase I and II
    Twelves, CJ
    Gardner, C
    Flavin, A
    Sludden, J
    Dennis, I
    de Bono, J
    Beale, P
    Vasey, P
    Hutchison, C
    Macham, MA
    Rodriguez, A
    Judson, I
    Bleehen, NM
    BRITISH JOURNAL OF CANCER, 1999, 80 (11) : 1786 - 1791
  • [4] Phase I and pharmacokinetic study of DACA (XR5000): a novel inhibitor of topoisomerase I and II
    C J Twelves
    C Gardner
    A Flavin
    J Sludden
    I Dennis
    J de Bono
    P Beale
    P Vasey
    C Hutchison
    M A Macham
    A Rodriguez
    I Judson
    N M Bleehen
    British Journal of Cancer, 1999, 80 : 1786 - 1791
  • [5] First-in-man study of HCV vaccine
    Nature Reviews Gastroenterology & Hepatology, 2015, 12 (1) : 5 - 5
  • [6] FIRST-IN-MAN STUDY OF E-3810, A NOVEL VEGFR AND FGFR INHIBITOR, IN PATIENTS WITH ADVANCED SOLID TUMORS
    Soria, J. C.
    Dienstmann, R.
    de Braud, F.
    Cereda, R.
    Bahleda, R.
    Hollebecque, A.
    Tabernero, J.
    Delmonte, A.
    Dromain, C.
    Lassau, N.
    Farace, F.
    Zucchetti, M.
    Marsoni, S.
    Camboni, M. G.
    ANNALS OF ONCOLOGY, 2012, 23 : 16 - 17
  • [7] A Novel System for Transcatheter Aortic Valve Implantation: First-in-Man Study
    Liu, Qingrong
    Mei, Ju
    Zhang, Hongliang
    Zhou, Wenbing
    Qiu, Kejin
    Zhou, Qing
    Chen, Yang
    Duan, Wei
    Zhou, Changping
    Tang, Min
    Huang, Jianbing
    Liu, Haixia
    Liu, Qingqing
    Chang, Rencao
    Niu, Guannan
    Zhang, Yuxin
    Wu, Tao
    Zhang, Ting
    Fang, Weiyi
    Wu, Yongjian
    Gao, Runlin
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 211 : 343 - 349
  • [8] First-in-man study of E-3810, a novel VEGFR and FGFR inhibitor, in patients with advanced solid tumors
    Soria, J. C.
    De Braud, F.
    Cereda, R.
    Bahleda, R.
    Delmonte, A.
    Angevin, E.
    Varga, A.
    Noberasco, C.
    Dall'O', E.
    Lassau, N.
    Dromain, C.
    Bellomi, M.
    Farace, F.
    Bertolini, F.
    Zucchetti, M.
    Marsoni, S.
    Camboni, M. G.
    ANNALS OF ONCOLOGY, 2011, 22 : 40 - 40
  • [9] Novel side branch ostial stent (BIGUARD™): first-in-man study
    Chen Shao-liang
    Zhang Jun-jie
    Ye Fei
    CHINESE MEDICAL JOURNAL, 2009, 122 (18) : 2092 - 2096
  • [10] First-in-man study of E-3810, a novel VEGFR and FGFR inhibitor, in patients with advanced solid tumors.
    Soria, J.
    De Braud, F. G.
    Cereda, R.
    Bahleda, R.
    Delmonte, A.
    Angevin, E.
    Varga, A.
    Noberasco, C.
    Dall'O, E.
    Lassau, N.
    Dromain, C.
    Bellomi, M.
    Farace, F.
    Bertolini, F.
    Zucchetti, M.
    Marsoni, S.
    Camboni, M. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345